Isoprenaline is a non-selective beta adrenergic receptor agonist indicated to treat heart block, Adams-Stokes attacks, bronchospasm in anesthesia, cadiac arrest, hypovolemic shocks, septic shock, hypoperfusion, congestive hear failure, and cardiogenic shock. Isoprenaline research in the 1940s found that this isopropyl analog of epinephrine dilated the bronchi, as well as raising the heart rate and cardiac output, without vasoconstriction. The US patent from 1943 states that this compound had a wider therapeutic index and a stronger action than [adrenaline]. Isoprenaline was granted FDA approval on 19 February 1948. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Novodrin, Isopropydrin, Asiprenol, Assiprenol and Bellasthman. Its PubChem CID is 3779.
Isoproterenol
| CAS No | 7683-59-2 |
|---|---|
| Molecular Formula | C11H17NO3 |
| Molecular Weight | 211.26 g/mol |
| Synonyms | 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Isoprenaline is a non-selective beta adrenergic receptor agonist indicated to treat heart block, Adams-Stokes attacks, bronchospasm in anesthesia, cadiac arrest, hypovolemic shocks, septic shock, hypoperfusion, congestive hear failure, and cardiogenic shock.
The listed CAS number is 7683-59-2.
The listed molecular formula is C11H17NO3.
The listed molecular weight is 211.26 g/mol.
4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol.
The source lists Novodrin, Isopropydrin, Asiprenol, Assiprenol and Bellasthman.